|
Age related macular degeneration or ARMD is the most
common cause of irreversible vision loss for people over the age of 60.
It is estimated that 2.5 million people in developed countries will suffer
visual loss from this disorder and that there are approximately 200,000
new cases diagnosed every year.
Macular degeneration is most common in people over the
age of 65 but there have been some cases affecting people as young as
their 40s and 50s. Symptoms include blurry or fuzzy vision, straight lines
like telephone poles and sides of buildings appear wavy and a dark or
empty area may appear in the center of vision.
The macula is the small portion of the retina located at the center of
this light sensitive lining at the back of the eye. Light rays from objects
that we are looking at come to a focus on the retina and are converted
into electrical impulses that are then sent to the brain. The macula is
responsible for sharp straight-ahead vision necessary for functions such
as reading, driving a car and recognizing faces.
The effect of this disease can range from mild vision
loss to central blindness. That is, blindness "straight ahead" but with
normal peripheral vision from the non-macular part of the retina which
is undamaged by the disease.
Ninety percent of ARMD is of the "atrophic" or "dry" variety. It is characterized
by a thinning of the macular tissue and the development of small deposits
on the retina called drusen. Dry ARMD develops slowly and usually causes
mild visual loss. The main symptom is often a dimming of vision when reading.
The second form of ARMD is called "exudative" or "wet"
because of the abnormal growth of new blood vessels under the macula where
they leak and eventually create a large blind spot in the central vision.
This form of the disease is of much greater threat to vision than the
more common dry type.
Unfortunately, the cause of this eye condition is not fully understood
but it is associated with the aging process. As we age, we become more
susceptible to numerous degenerative processes like arthritis, heart conditions,
cancer, cataracts and macular degeneration. These conditions may be caused
by the body's overproduction of free radicals.
During the metabolic process, oxygen atoms with an
extra electron are released. These extra electrons are quite destructive
and cause cellular damage, alter DNA, and are thought to be at least partially
responsible for many of the degenerative diseases mentioned above. The
production of these free radicals is normal during metabolism but the
body produces its own "anti-oxidants" to neutralize them.
Some of the vitamins in the food we eat also have anti-oxidant
properties. These are vitamins A, C, E and beta-carotene. Unfortunately,
smoking, poor nutrition and other lifestyle factors result in the body
producing too many free radicals. For this reason, lifestyle factors may
contribute to the risk of ARMD.
There is some evidence to suggest that ARMD has a genetic
basis, as the condition tends to run in families. The exact nature of
this familial tendency, however, has not been clarified. It has been suggested
from twin studies that there is a defect in the genes responsible for
the integrity and health of the retina.
Exposure to certain types of light may also play a
role. Studies performed on fishermen in the Chesapeake Bay suggest that
long-term exposure to ultraviolet light from the sun may increase the
risk of ARMD and other eye conditions such as the development of cataracts.
It has also been hypothesized that hyperopia or farsightedness
may also play a role in the development of the disease. It is thought
that the shortening of the eye in hyperopia may cause changes in the membrane
below the macula and in its blood vessels.
In the dry form of the disease, some form of inflammation
may also be a factor although what causes the inflammation is not known.
Although researchers are spending a great deal of time investigating the
cause and treatment of ARMD, there is no real cure available. The goal
of current treatment efforts is to attempt to stabilize the condition.
For the more severe wet form of the disease, doctors
have tried laser photocoagulation. This treatment, however, is not without
dangers and is only beneficial in the very early stages of the condition,
which is why early detection is so important. This technique involves
directing a beam of laser light at the abnormal blood vessels in order
to destroy them and prevent their leaking. Provided that the blood vessels
have not grown under the macula, this treatment can be helpful in arresting
the progress of the disease. If the blood vessels are already under the
macula, the laser may cause scarring and permanent vision loss.
Several new treatments are under development and scientific
evaluation.
A new type of treatment called photodynamic shows promise.
A drug, injected into the arm travels to the affected eye and is then
exposed to a non-thermal red light. This light activates the drug to close
and seal off the abnormal blood vessels. The entire treatment only takes
about 30 minutes and requires no anesthetic.
Treatment using proton beams, which release power at
predetermined target site and depth, has also been experimentally tested
for treatment of wet-ARMD.
No treatment exists for the dry form but many doctors are convinced that
a combination of specific vitamins and minerals helps slow the progression
of the disease. This has yet to be confirmed scientifically but there
are valid reasons for attempting this therapy. Anti-oxidant vitamins may
help to neutralize the free radicals that are associated with this degenerative
process. Zinc, one of the most common trace minerals in our body, is highly
concentrated in the retina and surrounding tissues and is a requirement
for chemical reactions in the retina.
Fat-soluble anti-oxidant vitamins like vitamin A and
vitamin E are stored in the body and can increase to toxic levels if over
used and zinc may interfere with other trace minerals like copper. Caution
should therefore be exercised in the use of vitamins and minerals.
|